शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
BSETitan Securities Ltd· FinanceHighNeutral
Announced Fri, 30 May, 2025 · 18:24 IST

AUDITED(STANDALONE AND CONSOLIDATED) FINANCIAL RESULTS FOR THE QUARTER AND FINANCIAL YEAR ENDED MARCH 31, 2025

Revenue growth above 20%Results View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.3%Reaction day
₹34.00
prior close
₹36.90
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.1%-0.4% vs market
Non Banking Financial Company (NBFC) peers, median of 194sector+0.0%-0.3% vs sector

On the reaction day the stock moved 0.4 pts less than Nifty Microcap 250 and 0.3 pts less than its Non Banking Financial Company (NBFC) peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-9.9
10m
-9.9
15m
-6.2
30m
-7.9
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.3+0.1-0.4+0.0-0.3
Next day
+0.7-0.2+0.9-0.4+1.2
2d
+0.3+0.3-0.0-0.3+0.6
3d
+0.9+0.9+0.0-0.3+1.2
4d
-0.0+0.8-0.8+0.1-0.2
5d
-1.1+2.2-3.2+0.8-1.8
1w
-1.1+3.4-4.4+1.0-2.1
15d
-4.4-0.8-3.7-1.4-3.0
1m
-2.6+2.9-5.6+1.2-3.8
2m
-8.9+0.8-9.7-1.9-6.9
3m
+1.9+0.0+1.9-3.0+4.9
UpDownMarket · Nifty Microcap 250Sector · Non Banking Financial Company (NBFC) peers, median of 194Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Titan Securities Ltd reported audited results for FY25 with standalone revenue from operations rising to ₹967.14 lakhs from ₹634.12 lakhs in FY24, a growth of roughly 52%. Standalone profit after tax stood at ₹113.25 lakhs (FY24: ₹107.39 lakhs), up about 5%, while Q4FY25 remained in the red at a loss of ₹10.88 lakhs. On a consolidated basis, including its share of profits from associates Titan Biotech and Peptech Biosciences (₹934.11 lakhs), net profit rose to ₹1,047.36 lakhs from ₹1,006.93 lakhs. The statutory auditor, A N S K & Associates, issued an unmodified (clean) opinion on both standalone and consolidated results, and the company separately filed a declaration confirming the same.

Likely market impact

Clean audit report and strong consolidated earnings driven by associate companies are positive signals for shareholders, though the standalone core business remains small and Q4 standalone slipped to a loss. Investors should note that consolidated profit depends heavily on associate performance, and cash balances dropped sharply from ₹135.78 lakhs to ₹11.75 lakhs due to investment purchases.